Similar articles for PMID: 17909261

Year	Number of Results
2003	1
2004	7
2005	13
2006	14
2007	24
2008	15
2009	15
2010	11
2011	13
2012	6
2013	12
2014	10
2015	9
2016	6
2017	1
2018	2
2019	3
2020	1
2021	3
2022	1
2023	1

1

18F-FDG PET in detecting primary breast cancer.

Kumar R, Lal N, Alavi A. Kumar R, et al. J Nucl Med. 2007 Oct;48(10):1751; author reply 1752. doi: 10.2967/jnumed.107.043265. J Nucl Med. 2007. PMID: 17909261 Free article. No abstract available.

2

Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.

Moy L, Ponzo F, Noz ME, Maguire GQ Jr, Murphy-Walcott AD, Deans AE, Kitazono MT, Travascio L, Kramer EL. Moy L, et al. J Nucl Med. 2007 Apr;48(4):528-37. doi: 10.2967/jnumed.106.036780. J Nucl Med. 2007. PMID: 17401088 Free article.

3

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Kauhanen SP, et al. Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa. Ann Surg. 2009. PMID: 19687736

4

Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.

Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS. Chang HT, et al. PLoS One. 2014 Dec 17;9(12):e115127. doi: 10.1371/journal.pone.0115127. eCollection 2014. PLoS One. 2014. PMID: 25517451 Free PMC article.

5

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M. Casneuf V, et al. Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8. Acta Gastroenterol Belg. 2007. PMID: 18330088

6

Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.

Gaeta CM, Vercher-Conejero JL, Sher AC, Kohan A, Rubbert C, Avril N. Gaeta CM, et al. Q J Nucl Med Mol Imaging. 2013 Dec;57(4):352-66. Q J Nucl Med Mol Imaging. 2013. PMID: 24322792 Free article. Review.

7

Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.

Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT. Ng SH, et al. J Clin Oncol. 2006 Sep 20;24(27):4371-6. doi: 10.1200/JCO.2006.05.7349. J Clin Oncol. 2006. PMID: 16983105

8

Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?

Bitencourt AG, Lima EN, Chojniak R, Marques EF, Souza JA, Andrade WP, Guimarães MD. Bitencourt AG, et al. Eur J Radiol. 2014 Aug;83(8):1381-6. doi: 10.1016/j.ejrad.2014.05.021. Epub 2014 May 27. Eur J Radiol. 2014. PMID: 24931922

9

18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?

Nguyen NQ, Bartholomeusz DF. Nguyen NQ, et al. J Gastroenterol Hepatol. 2011 Apr;26(4):613-5. doi: 10.1111/j.1440-1746.2011.06625.x. J Gastroenterol Hepatol. 2011. PMID: 21418296 No abstract available.

10

Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.

Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M. Ergul N, et al. Acta Radiol. 2015 Aug;56(8):917-23. doi: 10.1177/0284185114539786. Epub 2014 Jul 10. Acta Radiol. 2015. PMID: 25013091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed